Frazier Life Sciences Acquisition Corp. II (FLSC) SEC Filings, Oct 13, 2026

Frazier Life Sciences Acquisition Corp. II (FLSC) reports that director William Fairey directly holds 30,000 Class B ordinary shares as of October 13, 2026. The shares automatically convert into Class A ordinary shares on a one-for-one basis, subject to adjustment, immediately prior to, concurrently with or immediately following the consummation of the issuer’s initial business combination. William Fairey may also elect conversion at any time before then. The shares have no expiration date.